Orchid Buys GeneScreen, Diagnostic Testing Co.

Jan 15, 2000

Premium

P

RINCETON, NJ--Orchid Biocomputer has acquired GeneScreen, a genetic diversity analysis company based in Dallas. GeneScreen performs more than 1.5 million analyses of DNA per year, including analysis of SNPs, for a variety of applications and markets. The company intends to retain all of GeneScreen’s businesses and facilities in Dallas, Dayton, Ohio, and Sacramento, Calif., and to continue operations as a business unit of Orchid.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Main menu